266 related articles for article (PubMed ID: 27103259)
1. Gamma glutamyltransferase and risk of future dementia in middle-aged to older Finnish men: A new prospective cohort study.
Kunutsor SK; Laukkanen JA
Alzheimers Dement; 2016 Sep; 12(9):931-941. PubMed ID: 27103259
[TBL] [Abstract][Full Text] [Related]
2. γ-Glutamyltransferase and Risk of Sudden Cardiac Death in Middle-Aged Finnish Men: A New Prospective Cohort Study.
Kunutsor SK; Khan H; Laukkanen JA
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26857068
[TBL] [Abstract][Full Text] [Related]
3. Gamma-glutamyltransferase and risk of prostate cancer: Findings from the KIHD prospective cohort study.
Kunutsor SK; Laukkanen JA
Int J Cancer; 2017 Feb; 140(4):818-824. PubMed ID: 27861848
[TBL] [Abstract][Full Text] [Related]
4. Baseline and long-term gamma-glutamyltransferase, heart failure and cardiac arrhythmias in middle-aged Finnish men: Prospective study and pooled analysis of published evidence.
Kunutsor SK; Laukkanen JA; Bluemke DA; Butler J; Khan H
Eur J Prev Cardiol; 2016 Sep; 23(13):1354-62. PubMed ID: 27084895
[TBL] [Abstract][Full Text] [Related]
5. Gamma-Glutamyltransferase and Future Risk of Pneumonia: A Long-Term Prospective Cohort Study.
Kunutsor SK; Laukkanen JA
Lung; 2017 Dec; 195(6):799-803. PubMed ID: 28993933
[TBL] [Abstract][Full Text] [Related]
6. Gamma-glutamyltransferase and risk of chronic kidney disease: A prospective cohort study.
Kunutsor SK; Laukkanen JA
Clin Chim Acta; 2017 Oct; 473():39-44. PubMed ID: 28811239
[TBL] [Abstract][Full Text] [Related]
7. Gamma-Glutamyl Transferase Variability and Risk of Dementia in Diabetes Mellitus: A Nationwide Population-Based Study.
Hong SH; Han K; Park S; Kim SM; Kim NH; Choi KM; Baik SH; Park YG; Yoo HJ
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31955208
[TBL] [Abstract][Full Text] [Related]
8. Is lipoprotein (a) protective of dementia?
Kunutsor SK; Khan H; Nyyssönen K; Laukkanen JA
Eur J Epidemiol; 2016 Nov; 31(11):1149-1152. PubMed ID: 27412033
[TBL] [Abstract][Full Text] [Related]
9. Gamma-glutamyltransferase levels, prediabetes and type 2 diabetes: a Mendelian randomization study.
Nano J; Muka T; Ligthart S; Hofman A; Darwish Murad S; Janssen HLA; Franco OH; Dehghan A
Int J Epidemiol; 2017 Oct; 46(5):1400-1409. PubMed ID: 28338987
[TBL] [Abstract][Full Text] [Related]
10. Circulating gamma glutamyltransferase and prediction of cardiovascular disease.
Kunutsor SK; Bakker SJ; Kootstra-Ros JE; Gansevoort RT; Dullaart RP
Atherosclerosis; 2015 Feb; 238(2):356-64. PubMed ID: 25555268
[TBL] [Abstract][Full Text] [Related]
11. Gamma-glutamyl transferase variability and risk of dementia: A nationwide study.
Lee YB; Han K; Park S; Kim SM; Kim NH; Choi KM; Baik SH; Park YG; Yoo HJ
Int J Geriatr Psychiatry; 2020 Oct; 35(10):1105-1114. PubMed ID: 32392636
[TBL] [Abstract][Full Text] [Related]
12. Gamma-glutamyltransferase and risk of cardiovascular disease mortality in people with and without diabetes: pooling of three British Health Surveys.
Kengne AP; Czernichow S; Stamatakis E; Hamer M; Batty GD
J Hepatol; 2012 Nov; 57(5):1083-9. PubMed ID: 22796154
[TBL] [Abstract][Full Text] [Related]
13. Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women.
Lee DH; Silventoinen K; Hu G; Jacobs DR; Jousilahti P; Sundvall J; Tuomilehto J
Eur Heart J; 2006 Sep; 27(18):2170-6. PubMed ID: 16772340
[TBL] [Abstract][Full Text] [Related]
14. Association between γ-glutamyltransferase level and incidence of atrial fibrillation: A nationwide population-based study.
Lee SR; Choi EK; Han KD; Cha MJ; Oh S
Int J Cardiol; 2017 Oct; 245():149-155. PubMed ID: 28757090
[TBL] [Abstract][Full Text] [Related]
15. Serum γ-glutamyltransferase: independent predictor of risk of diabetes, hypertension, metabolic syndrome, and coronary disease.
Onat A; Can G; Örnek E; Çiçek G; Ayhan E; Doğan Y
Obesity (Silver Spring); 2012 Apr; 20(4):842-8. PubMed ID: 21633402
[TBL] [Abstract][Full Text] [Related]
16. Serum γ-glutamyltransferase and the risk of heart failure in men and women in Finland.
Wang Y; Tuomilehto J; Jousilahti P; Salomaa V; Li B; Antikainen R; Mähönen M; Katzmarzyk PT; Hu G
Heart; 2013 Feb; 99(3):163-7. PubMed ID: 23144292
[TBL] [Abstract][Full Text] [Related]
17. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults.
Ruttmann E; Brant LJ; Concin H; Diem G; Rapp K; Ulmer H;
Circulation; 2005 Oct; 112(14):2130-7. PubMed ID: 16186419
[TBL] [Abstract][Full Text] [Related]
18. Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels.
Haring R; Wallaschofski H; Nauck M; Dörr M; Baumeister SE; Völzke H
Hepatology; 2009 Nov; 50(5):1403-11. PubMed ID: 19670414
[TBL] [Abstract][Full Text] [Related]
19. Serum gamma-glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population.
Meisinger C; Döring A; Schneider A; Löwel H;
Atherosclerosis; 2006 Dec; 189(2):297-302. PubMed ID: 16483579
[TBL] [Abstract][Full Text] [Related]
20. Gamma-Glutamyltransferase (GGT) as a biomarker of cognitive decline at the end of life: contrasting age and time to death trajectories.
Praetorius Björk M; Johansson B
Int Psychogeriatr; 2018 Jul; 30(7):981-990. PubMed ID: 29108523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
